Novel treatment of meningitis caused by multidrug-resistant Mycobacterium tuberculosis with intrathecal levofloxacin and amikacin:: Case report

被引:33
作者
Berning, SE
Cherry, TA
Iseman, MD
机构
[1] Univ Colorado, Sch Pharm, Natl Jewish Med & Res Ctr, Dept Med, Denver, CO 80206 USA
[2] Univ Colorado, Sch Med, Natl Jewish Med & Res Ctr, Dept Med, Denver, CO USA
关键词
D O I
10.1086/318698
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We report the case of a 25-year-old HIV-negative man with disseminated multidrug-resistant tuberculosis (MDRTB), who-on a retreatment regimen-experienced total resolution of TB miliary disease, but progressive TB meningitis. Therefore, intrathecal treatment with amikacin and levofloxacin was instituted, with successful clinical and microbiological results.
引用
收藏
页码:643 / 646
页数:4
相关论文
共 10 条
[1]   CEREBROSPINAL-FLUID CONCENTRATIONS OF ETHIONAMIDE IN CHILDREN WITH TUBERCULOUS MENINGITIS [J].
DONALD, PR ;
SEIFART, HI .
JOURNAL OF PEDIATRICS, 1989, 115 (03) :483-486
[2]   PENETRATION OF PYRAZINAMIDE INTO THE CEREBROSPINAL-FLUID IN TUBERCULOUS MENINGITIS [J].
ELLARD, GA ;
HUMPHRIES, MJ ;
GABRIEL, M ;
TEOH, R .
BRITISH MEDICAL JOURNAL, 1987, 294 (6567) :284-285
[3]   CEREBROSPINAL-FLUID DRUG CONCENTRATIONS AND THE TREATMENT OF TUBERCULOUS MENINGITIS [J].
ELLARD, GA ;
HUMPHRIES, MJ ;
ALLEN, BW .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 148 (03) :650-655
[4]   The clinical pharmacokinetics of levofloxacin [J].
Fish, DN ;
Chow, AT .
CLINICAL PHARMACOKINETICS, 1997, 32 (02) :101-119
[5]   PYRAZINAMIDE STERILIZING ACTIVITY INVITRO AGAINST SEMIDORMANT MYCOBACTERIUM-TUBERCULOSIS BACTERIAL-POPULATIONS [J].
HEIFETS, L ;
LINDHOLMLEVY, P .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 145 (05) :1223-1225
[6]   Antibiotic pharmacodynamics in cerebrospinal fluid [J].
Lutsar, I ;
McCracken, GH ;
Friedland, IR .
CLINICAL INFECTIOUS DISEASES, 1998, 27 (05) :1117-1127
[7]   THE ACTION OF ANTITUBERCULOSIS DRUGS IN SHORT-COURSE CHEMOTHERAPY [J].
MITCHISON, DA .
TUBERCLE, 1985, 66 (03) :219-225
[8]   Using therapeutic drug monitoring to dose the antimycobacterial drugs [J].
Peloquin, CA .
CLINICS IN CHEST MEDICINE, 1997, 18 (01) :79-&
[9]  
PELOQUIN CA, 1991, DRUG SUSCEPTIBILITY, P13
[10]   PREDICTORS AND OUTCOME OF MULTIDRUG-RESISTANT TUBERCULOSIS [J].
SALOMON, N ;
PERLMAN, DC ;
FRIEDMANN, P ;
BUCHSTEIN, S ;
KREISWIRTH, BN ;
MILDVAN, D .
CLINICAL INFECTIOUS DISEASES, 1995, 21 (05) :1245-1252